Search results for: hospital

Difficult-to-Treat Lupus: When & How to Use New Therapies

Samantha C. Shapiro, MD | July 21, 2022

Clinicians have numerous treatment options for SLE; in a EULAR 2022 session, some of the newer therapies were reviewed.

Biologic or Conventional Therapy for Early RA?

Michele B. Kaufman, PharmD, BCGP | July 19, 2022

A study has shown that in untreated patients with early RA, treatment with methotrexate combined with the biologic therapies abatacept or certolizumab-pegol resulted in greater CDAI remission rates than active conventional therapy with prednisolone, sulfasalazine or hydroxychloroquine.

Phase 2 Study Shows Promising Results for Deucravacitinib in PsA

Michele B. Kaufman, PharmD, BCGP | July 19, 2022

Research has demonstrated that deucravacitinib is significantly more efficacious than placebo for achieving minimal disease activity in patients with active PsA after 16 weeks of treatment.

Baricitinib Promising for Juvenile Idiopathic Arthritis

Michele B. Kaufman, PharmD, BCGP | July 19, 2022

In a study from Ramanan et al., baricitinib proved safe and effective for reducing the time to flare and frequency of flare in patients aged 2–18 years with juvenile idiopathic arthritis.

Spine School: Axial Manifestations of Psoriatic Arthritis

Jason Liebowitz, MD, FACR | July 15, 2022

This EULAR 2022 session emphasized the importance of recognizing the axial manifestations of psoriatic arthritis and treating these symptoms accordingly.

Study Compares Intra-Articular Morphine with Steroids & Placebo in Patients with Chronic Knee Arthritis

Michele B. Kaufman, PharmD, BCGP | July 15, 2022

A study from Haibel et al. in patients with chronic knee arthritis found intra-articular morphine did not lead to a significant, short-term reduction in pain compared with placebo and proved inferior to treatment with intra-articular triamcinolone.

Never Too Late: Late-Breaking Abstracts Create Excitement

Jason Liebowitz, MD, FACR | July 15, 2022

EULAR 2022 (VIRTUAL)—The pace of scientific progress in research medicine is incredible and seems to only accelerate with time. Thus, the 2022 Congress of the European Alliance of Associations for Rheumatology (EULAR) session on late-breaking abstracts fittingly captured the excitement and timeliness of a number of research projects that have just recently been completed and…

Clinical Guidance & Recommendation Updates for Vasculitis, axSpA & More

Jason Liebowitz, MD, FACR | July 15, 2022

In this EULAR 2022 session, new & revised treatment recommendations for ANCA-associated vasculitis, axial spondyloarthritis & rheumatoid arthritis were presented.

Rheum After 5: Music, Medicine & Manure

Carol Patton | July 14, 2022

Elliot Rosenstein, MD, spends most weekend mornings and late afternoons a bit differently than other rheumatologists. He feeds and waters chickens, rabbits, llamas, horses, goats and guinea fowl, as well as an orphaned peacock. Dr. Rosenstein is one of two medical directors at the Institute of Rheumatic & Autoimmune Disease (IRAD) at Overlook Medical Center,…

Ethics Forum: Billing, Burnout and Protected Non-Clinical Time

Beenish Zulfiqar, MD | July 14, 2022

It’s 11 a.m. on a Wednesday. You see a new patient in your fellow’s clinic with impressive physical findings, including a prominent skin rash and deforming arthritis. The patient has been to many doctors and is frustrated that her condition remains undiagnosed and untreated. You thoroughly examine the patient, present her case to your attending…